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Abstract: Long-term alcohol exposure may lead to development of alcohol dependence in consequence of altered neuro-
transmitter functions. Accumulating evidence suggests that the N-methyl-D-aspartate (NMDA) type of glutamate recep-
tors is a particularly important site of ethanol’s action. Several studies showed that ethanol potently inhibits NMDA recep-
tors (NMDARs) and prolonged ethanol exposition leads to a compensatory “up-regulation” of NMDAR mediated func-
tions. Therefore, alterations in NMDAR function are supposed to contribute to the development of ethanol tolerance, de-
pendence as well as to the acute and late signs of ethanol withdrawal. 
A number of publications report alterations in the expression and phosphorylation states of NMDAR subunits, in their in-
teraction with scaffolding proteins or other receptors in consequence of chronic ethanol treatment. Our knowledge on the 
regulatory processes, which modulate NMDAR functions including factors altering transcription, protein expression and 
post-translational modifications of NMDAR subunits, as well as those influencing their interactions with different regula-
tory proteins or other downstream signaling elements are incessantly increasing. The aim of this review is to summarize 
the complex chain of events supposedly playing a role in the up-regulation of NMDAR functions in consequence of 
chronic ethanol exposure. 
Key Words: Alcohol dependence, NMDA receptor, subunit expression, post-translation modifications, phosphorylation/ 
dephosphorylation, compartmentalization. 
INTRODUCTION 
  Alcoholism is a devastating disease defined as a chronic 
and progressive disorder that includes development of toler-
ance to alcohol (ethanol), alcohol dependence, i.e. an uncon-
trolled consumption of alcohol despite the negative conse-
quences, and craving and/or manifestation of withdrawal 
syndrome when alcohol is removed. Alcoholism ranks as one 
of the main current threats to the health and safety of people 
in most Western countries, affecting about 14 million people 
in the United States with a society cost about $165 billion a 
year [155]. Long-term and uncontrollable alcohol consump-
tion can cause other disorders that include: antisocial person-
ality disorder, mood and anxiety disorders.  
  Investigation targeting mechanisms underlying the ac-
tions of ethanol in the central nervous system (CNS) has 
been ongoing for more than a century. Early research on the 
actions of alcohol focused on the physical properties of alco-
hols and established the widely appreciated Meyer-Overton 
relation that describes the direct relationship between the 
hydrophobicity of an alcohol and its potency for producing 
intoxication [113, 134]. According to this “lipid theory” of 
alcohols’ action, ethanol is thought to produce its effects by 
actions on the membrane lipids bringing about changes in the 
function of the membrane proteins. Consistent with this hy-
pothesis, the intoxicating potency of aliphatic n-alcohols 
with up to five carbon atoms is correlated with both their 
lipid solubility and their membrane lipid disordering po-
tency. However, the potency of aliphatic n-alcohols for pro-
ducing intoxication reaches a maximum at six to eight car- 
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bon atoms and then decreases [2, 54, 138]. The molecular 
bases of this “cut-off” effect cannot be explained by the 
“lipid theory”, since both lipid solubility and membrane lipid 
disordering potency increase exponentially with the increase 
in the carbon chain length. The cut-off in ethanol’s effect as 
well as data demonstrating that definite subunit composition 
and certain amino-acid residues of sensitive receptors are 
critical for allosteric modulation by ethanol challenged the 
hypothesis of ethanol’s non-specific membrane effects [3, 
88, 114, 178]. 
  Although, the exact mechanism by which ethanol exerts 
its effect is still a matter of debate, studies over the last dec-
ade showed that ethanol, affecting several neurotransmitter 
systems, differentially modifies processes of neurotransmis-
sion in the CNS. Besides altering the release of neurotrans-
mitters like dopamine (DA) - resulting in increased DA lev-
els in the “central reward” pathway -, ethanol alters the func-
tion of a number of neurotransmitter receptors (e.g.: -amino 
butyricacid A (GABAA),glycine, glutamate, nor-epinephrine, 
DA, serotonin, acetylcholine) as well as transporters (adeno-
sine, nor-epinephrine, DA, serotonin). Especially the ligand-
gated ion channels including those belonging to the brain's 
major amino acid neurotransmitter systems – the inhibitory 
GABA and the excitatory glutamate receptors – were shown 
highly sensitive to the acute effect of ethanol at relevant 
(<100 mM) concentrations [49, 96, 103]. In the past years, 
there has been increasing evidence of facts that acute ethanol 
facilitates GABAergic transmission by enhancing chloride 
conductance of the GABAA receptors, and inhibits glutama-
tergic function by decreasing the flow of cations especially 
through the NMDA activated subclass of glutamate recep-
tors.Furthermore,afterchronic ethanol consumption, reduced 
GABAergic and increased glutamatergic functions have been 
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underlying the development of alcohol tolerance and de-
pendence. Among glutamate receptors, AMPA and espe-
cially NMDA type of receptors were shown to represent the 
highest affinity targets for ethanol in the CNS [56, 57, 66, 
86, 102]. Biochemical, electrophysiological as well as be-
havioral evidences also supported the conception that ethanol 
can serve as a potent and selective inhibitor of these recep-
tors [31, 37, 65, 102, 104]. 
STRUCTURE AND FUNCTION OF NMDA RECEP-
TORS 
  NMDA receptors belong to the family of ionotropic glu-
tamate receptors, and are abundantly expressed in the CNS. 
The involvement of these receptors in diverse neural func-
tions like excitatory synaptic transmission, synaptic plastic-
ity, and excitotoxicity rests upon their unique features, i.e. 
their special characteristics like high permeability to Ca
2+ 
ions, the relatively slow activation / deactivation kinetics and 
their voltage-sensitive blockage by Mg
2+ ions. Due to this 
Mg
2+ block occurring physiologically at voltages close to the 
resting membrane potential, glutamate, the native agonist of 
these receptors can open the ion-channel only if the cell is 
depolarized, typically upon AMPA/kainate receptor activa-
tion. Subsequent to relief of the Mg
2+ block, NMDARs per-
mit the entry of Ca
2+ ions that can activate secondary mes-
senger cascades. By this means, NMDARs act as coinci-
dence perceptive elements, which become active only when 
electrical and chemical signals are present concurrently [3]. 
  Besides glutamate, NMDARs are sensitive to several 
other endogenous modulators. For full receptor activation, 
the co-agonist glycine [112] or D-serine [120] must also bind 
to the receptor. Endogenous polyamines, spermine and sper-
midine also facilitate [95, 150], whereas extracellular protons 
[169, 175] and Zn
2+ ions [27] suppress NMDAR activation. 
In addition, NMDARs interact with various intracellular 
scaffolding, anchoring, and signaling molecules associated 
with the postsynaptic density (Fig. 1). The sensitivity of 
NMDARs to different ligands, its permeation and blockade 
by divalent ions, kinetic properties, and interaction with in-
tracellular proteins highly depend on their subunit composi-
tion [32, 74]. 
  NMDARs, like other ion-channel receptors, are mul-
timeric transmembrane proteins, assembled of different types 
of subunits. Several distinct NMDAR subunits have been 
identified in neurons (Fig. 2). The ubiquitously expressed 
NR1 subunit occurs as eight distinct isoforms because of 
three independent sites of alternative splicing (N1, C1 and 
Fig. (1). Schematic model of NMDA glutamate receptor illustrating multiple regulatory sites.
The NMDA glutamate receptor appears to be comprised of 4 subunits, including 2 NR1 subunits and 2 NR2 subunits. This figure illustrates a 
receptor with an NR2A subunit (in the rear) and an NR2B subunit (in front). Each subunit contains 4 transmembrane domains (TM1–TM4), 
of which TM2 constitutes a key element of the Ca
2+ pore (Kupper et al., 1996). The TM3 region of the NR1 subunit, and perhaps other 
subunits, appears to be associated with ethanol binding (Ronald et al., 2001). The N-terminal cassette does not appear to be a binding site for 
ethanol (Popp et al., 1998) but does contain critical sites for modulation, including Zn
2+ and redox agents (NR2A) or protons, polyamines, 
and ifenprodil (NR2B) (reviewed in the text and in Paoletti et al., 1997, 2000; Choi et al., 2001). The glycine-B (GlyB) sites are located in 
the extracellular domains. The intracellular cassettes of the NR1 contain the sites at which PKA and PKC phosphorylate and PP1 dephos-
phorylates this subunit. Yotiao (Y) is an NR1-binding protein. The NR1 subunit also contains a site that attaches this subunit to the cy-
toskeleton via -actinin-2. The intracellular domain of the NR2 subunits contain phosphorylation sites for the tyrosine kinases (Fyn and Src), 
CaM kinase II (CaM KII), and PDZ-containing anchoring proteins (PSD-95, chapsyn-110/PSD-93, and SAP-102) that in turn attach NR2
subunits to the cytoskeleton via other proteins (GKAP, Shank, and cortactin). Modified from Woodward (2000) and Millan (2002). 
(John H. Krystal, Ismene L. Petrakis, Graeme Mason, Louis Trevisan, D. Cyril D’Souza (2003) N-methyl-D-aspartate glutamate receptors 
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C2 cassettes). Families of four NR2 (A, B, C and D) and two 
NR3 (A, B) subunits are also identified [35, 67, 118]. Al-
though, the precise subunit composition and stoichiometry of 
native NMDARs are difficult to determine and largely un-
known [92, 141], it is believed that NMDARs exist as 
tetrameric complexes consisting of at least one NR1 and one 
NR2 subunits [116-118]. The subunits are most probably 
arranged as dimer of dimers with an NR1-NR1-NR2-NR2 
orientation in the channel [160]. Each subunit has four hy-
drophobic regions, although only three of them form mem-
brane-spanning domains (TM1, TM3, and TM4). The fourth 
one (M2) makes a hairpin bend within the membrane and 
participate in the formation of the ion-channel pore [32]   
(Fig. 3). 
  Two important composition-dependent properties of   
the NMDARs include their single-channel conductance [21] 
and their block by extracellular Mg
2+ ions. Diheteromeric 
NMDARs composed of NR1/NR2A or NR1/NR2B subunits 
produce ‘high-conductance’ channel openings with a high 
sensitivity to Mg
2+ blockade. On the contrary, receptors con-
taining NR2C or NR2D subunits give rise to ‘low-conduc-
tance’ channels with a lower sensitivity to extracellular Mg
2+
ions. The NR3 subunits are thought to be regulatory in nature 
since they do not form functional channels with NR1 but can 
co-assemble with NR1/NR2 complexes [35]. NMDARs con-
taining NR3 subunits form ‘low-conductance’ channels. In-
sertion of an NR3 subunit into NR1/NR2A complexes show 
a roughly five-fold reduction in relative Ca
2+ permeability 
compared to those composed of merely NR1/NR2A subunits 
[139]. 
  One of the NR2 subunits, the NR2B type appears to be 
especially important in respect of several functional proper-
ties of the NMDAR. It determines channel’s sensitivity to 
Mg
2+ block. Replacement of Trp607 of this subunit to Asp or 
Ala greatly attenuates while substitution of this amino acid 
side chain for Leu completely abolishes the ability of Mg
2+
to block NMDAR function. According to these observations, 
Williams et al. [187] proposed a model in which the M2 loop 
of the NR2B subunit containing the Trp607 is part of the 
binding site for Mg
2+ ions. The presence of an NR2B subunit 
in the receptor complex affects the binding of the co-agonist 
glycine as well. Whereas the binding site for glycine is 
thoughtto be located on the NR1 subunit [32], a high-affinity 
site for CGP61594, a glycine site antagonist, was shown 
exclusively displayed by NR1/NR2B receptors as compared 
to receptors containing other assemblies of NR2 subunits 
[68]. One of the unique characteristics of the NR2B subunit 
is that it binds polyamines. Polyamines appear to facilitate 
NMDAR function, probably by reducing the inhibitory im-
pact of protons [52]. The NR2B subunit is a highly relevant 
candidate for mediating the modulatory effects of poly-
amines, such as spermine and spermidine. In addition, simi-
larly to polyamines, ifenprodil [8], the prototype of the re-
cently discovered NR2B subunit selective NMDAR antago-
nists (SSNAs) and related compounds – e.g. eliprodil, CP-
101,606, Ro25-6981 or RG-1103 [9, 18, 51, 78, 185, 186] – 
selectively antagonize NMDA responses in those receptors 
that contain NR2B subunit. 
EFFECTS OF ETHANOL ON AGONIST INDUCED 
NMDAR ACTIVATION 
  Ethanol withdrawal is thought to be a physiopathological 
state associated with increased number and function of 
NMDARs. Primarily this conception was based on the ob-
servations that in ethanol-withdrawn animals, after interrup-
tion of the chronic ethanol treatment, the focal application of 
NMDA was five-fold more potent than in control animals. In 
addition, the non-competitive NMDAR antagonist dizocil-
pine (MK-801) or ethanol markedly reduced the NMDA-
induced increase in glutamate levels. These results are con-
sistent with the up-regulation of NMDARs by chronic etha-
nol exposure and supply biochemical evidence for the pres-
ence of NMDARs facilitating glutamate release possibly 
through positive feedback mechanisms [42, 157]. 
  Levels of aspartate, glycine, and N-acetylaspartylgluta-
mate in cerebrospinal fluid (CSF) obtained from alcohol de-
pendent patients were all higher than those of the comparison 
subjects. On the contrary, the concentration of GABA in 
their CSF was lower. In addition, there were significant cor-
relations between excitatory neurotransmitters and oxidative 
Fig, (2). NMDAR subunit diversity.
(a) Dendrogram of complete amino-acid sequences for rat NMDAR 
subunits.  (b)  Representation of NMDAR subunit polypeptides. 
Black boxes indicate transmembrane domains, and grey boxes show 
the transmembrane TM2 re-entrant loop. Asterisks denote regions at 
which alternative splicing takes place. This is best characterized for 
the NR1 subunit, which has three regions of alternative splicing: the 
amino-terminal N1 cassette (exon 5); and the carboxy-terminal C1 
(exon 21) and C2 (exon 22) cassettes. Splicing at these sites can 
generate eight distinct isoforms (NRI-1a, -1b, -2a, -2b, -3a, -3b, -4a 
and -4b). Splicing of the NR2C subunit leads to truncated polypep-
tides ending after TM1 or TM3. The NR2D subunit can be spliced 
in the carboxyl terminus, producing a 33-amino-acid insert. Like-
wise, NR3A splicing leads to a 20-aminoacid insert in the carboxy-
terminal domain. NR2B, NR2C and NR2D also have splice sites in 
their 5-untranslated regions but no splice variants have been re-
ported for NR2A. 
(Stuart Cull-Candy, Stephen Brickley and Mark Farrant (2001) 
NMDA receptor subunits: diversity, development and disease. 
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stress markers, which suggest that the two mechanisms may 
play an interactive role in neurotoxicity mediated by ethanol 
withdrawal [177]. 
  Clinical investigations and animal experiments showed 
that chronic alcohol consumption leads to elevated plasma 
levels of the NMDAR co-agonist, homocysteine [12, 13, 15]. 
Homocysteine has a role in biochemical cascades involving 
overstimulation of NMDARs, oxidative stress, mitochondrial 
dysfunction, activation of caspases and DNA damage. These 
mechanisms are thought to be important in the pathogenesis 
of both excitotoxicity and apoptotic neurotoxicity. Increased 
levels of homocysteine in chronic alcoholism was also 
shown to be associated with brain atrophy, therefore high 
plasma homocysteine levels are suggested as a good predic-
tor of alcohol withdrawal seizures and brain damage giving 
opportunity for early anticonvulsive and neuroprotective 
intervention [13, 14, 16]. 
 In  an  in vitro study, we investigated the alterations in the 
inhibitory activity of different NMDA receptor antagonists 
due to chronic and repeated ethanol pre-treatment in primary 
cultures of rat cortical and hippocampal neurons [126]. The 
inhibitory activity of the channel blocking agent MK-801 or 
the glycine-site selective antagonist 5,7-DCK was unchanged 
in primary cortical cultures after 3 days of repeated ethanol 
(100 mM) pre-treatment. This is in agreement with the pre-
vious findings of al-Qatari et al. [6], who observed no 
changes in the effect of the competitive NMDA receptor 
antagonist D-APV on NMDA induced calcium entry in etha-
nol pre-treated neocortical cultures. On the contrary, we 
found that NR2B subunit selective antagonists – ifenprodil, 
CP-101,606 and CI-1041 – as well as ethanol itself reduced 
NMDA induced calcium responses more potently in the 
ethanol pre-treated than in control cultures. The maximal 
inhibitoryeffects of these compounds significantly increased, 
and their IC50 values slightly, although insignificantly de-
creased due to ethanol pre-treatment. Similarly, the effec-
tiveness of ifenprodil was shown to be increased in cortical 
cultures after 4 days of 100 mM ethanol pre-treatment [17], 
and supersensitivity to ethanol was also observed in pontine 
slice preparations from ethanol treated (3 g/kg daily for 14 
days, i.p.) rats 24 h after the last ethanol dose [140]. NMDA 
evoked rise in cytosolic calcium level as well as NMDA in-
duced excitotoxicity were found to be potentiated in ethanol-
Fig. (3). Potential sites for ligand binding at NMDARs.  
Most NMDAR are believed to assemble as tetramers, associating two NR1 and two NR2 subunits in a ‘dimer of dimers’ quaternary architec-
ture. For clarity, only one of the two NR1/NR2 heterodimers is shown. The extracellular region of each subunit is made up of a tandem of 
bilobate ‘Venus-flytrap’ domains, the NTD and the ABD. In the extracellular region, the subunits dimerize at the level of the ABDs and 
probably also at the level of the NTDs. The NR2 ABD binds glutamate, whereas the NR1 ABD binds the co-agonist glycine (or D-serine). 
White arrows indicate binding sites for competitive agonists and antagonists. Thick orange arrows indicate sites known to bind allosteric 
modulators such as endogenous zinc (NR2A and NR2B NTDs) or ifenprodil-like compounds (NR2B NTDs), both acting as non-competitive
antagonists. The ion-channel domain also forms binding sites for pore blockers such as endogenous Mg
2+, MK-801, memantine or ketamine, 
acting as uncompetitive antagonists. Thin orange arrows indicate putative modulatory sites, which can bind either positive or negative allos-
teric modulators. The only known NMDAR antagonists that display strong subunit selectivity are the NR2 NTD ligands Zn
2+, which selec-
tively inhibits NR2A-containing receptors at nanomolar concentrations, and ifenprodil-like compounds, which selectively inhibit NR2B-
containing receptors. 
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treated primary cortical and hippocampal cultures, too [1, 
125, 159, 163]. Furthermore, after several days of ethanol 
(100 mM) pre-treatment followed by 24-hour withdrawal, 
increased cell death was observed in primary cultures of rat 
cortical neurons [123] and in rat entorhinal/hippocampal 
slice cultures [28]. In this later model the cytotoxic effect of 
ethanol withdrawal was enhanced by the NMDA receptor 
co-agonist spermine [142]. Taken together, these data sup-
port the conception that enhanced efficiency of NR2B 
subunit selective antagonists supposedly in consequence of 
increased expression of the NR2B subunit containing recep-
tor complexes underlies the augmentation of NMDAR func-
tions. 
  Besides the above mentioned NR2B subunit selective 
antagonists, the novel abstinence-promoting drug acampro-
sate (calcium acetylhomotaurinate) used in the treatment of 
alcohol dependence was also shown to effectively inhibit the 
cytotoxic effect of ethanol withdrawal in ethanol pre-treated 
primary cortical cultures [127]. Even though, it did not in-
hibit the NMDA-evoked cytoplasmic calcium elevation in 
neurons up to 300 DM, it showed a 75% reduction in with-
drawal-evoked LDH release at the same concentration. Al-
though the precise mechanism of action of acamprosate is 
not clearly known, there is an evidence for an interaction 
between acamprosate and the NMDARs based on electro-
physiological as well as radioligand binding studies. Initial 
electrophysiological studies showed that acamprosate de-
pressed excitatory postsynaptic potentials mediated by glu-
tamic acid and selectively inhibited direct activation of these 
same neurons by NMDA in rat cortical slices in vitro [202]. 
However, later studies described potentiation of NMDA re-
sponses in hippocampal slices [107]. In addition, Popp and 
Lovinger [141] showed that acamprosate acts at the poly-
amine site on the NMDAR and inhibits potentiation of 
NMDAR activation by the polyamine site ligand spermine. 
According to these observations acamprosate seems to inter-
act with a regulatory site on the NMDAR, such that the 
magnitude and direction of the effect of acamprosate is de-
termined by the resting level of NMDAR activity. Naassila 
et al. [122] described a low-affinity but saturable binding site 
for [
3H]-acamprosate on rat brain membranes. The binding 
of [
3H]-acamprosate could be displaced by spermidine and 
other polyamines and they described also the displacement 
of [
14C]-spermidine binding by acamprosate at similar con-
centrations. In another study, al Qatari et al. [5] reported that 
under conditions of low NMDA receptor activation, acam-
prosate potentiated [
3H]-dizolcipine binding, whereas, at 
high levels of receptor activation, binding was inhibited. 
Interestingly, the potentiating effect of acamprosate on [
3H]-
dizolcipine binding was lost in membranes prepared from 
rats made dependent on alcohol. This finding was explained 
by a change in the subunit composition of the NMDA recep-
tor as a result of chronic alcohol exposure. Taken together, 
the electrophysiological and radioligand binding studies dis-
cussed previously are compatible with the hypothesis that 
acamprosate has a partial agonist activity at an allosteric 
regulatory site, possibly the polyamine site, on the NMDAR. 
The interaction of acamprosate with this site is activity-
dependent, it means that at low levels of receptor activation, 
acamprosate would substitute for polyamines and facilitate 
NMDA receptor activation and at high levels of receptor 
activation, acamprosate would have an antagonist effect, 
attenuating receptor activation [36]. 
  Neurosteroidsarealsoimportantmodulators of NMDARs. 
In various brain areas, neurosteroid concentrations change in 
response to alterations of particular physiological conditions, 
and during behavior associated with stress, sexual activity or 
aggressiveness [29, 136]. In all probability, neurosteroids 
influence cerebral activity by directly affecting the function 
of membrane receptors. Neurosteroids known to interact 
with GABAA and NMDA receptors include: 3-hydroxy-5-
pregnen-20-one-3-sulfate (pregnenolone sulfate) (PS); dehy-
droepiandrosterone sulfate(DHEAS); 3-hydroxy-5-pregnan-
20-one (35 allopregnanolone); 3-hydroxy-5-pregnan-20-
one (35 pregnanolone) and 3-hydroxy-5-pregnan-20-one 
sulfate (35S pregnanolone sulfate) [91, 108, 135]. Previ-
ously it was suggested that estrogen and PS might directly 
modulate NMDA receptors increasing both the frequency of 
opening and the mean open time of the ion-channel [19, 
191].Furthermore,acuteadministrationof alcohol was shown 
to increase the concentrations of the neurosteroids, preg-
nenolone and allopregnanolone [142]. Conversely, during 
EtOH withdrawal decreased endogenous allopregnanolone 
levels were found in seizure-prone animals [45, 75]. Costa et
al. showed that prenatal ethanol exposure can modify the 
allosteric modulation of NMDARs by neurosteroids. Primary 
cultures of hippocampal neurons were prepared from the 
neonataloffsprings of dams exposed to an ethanol-containing 
liquid diet that results in blood ethanol levels near the intoxi-
cation limit, and NMDA receptor function was assessed by 
patch clamp electrophysiological techniques after 6-7 days in 
culture in ethanol-free media. Whereas, they did not detect 
any change in hippocampal NMDA receptor function at ei-
ther the whole-cell or single-channel levels, they observed 
alterations in the actions of the neurosteroids pregnenolone 
sulfate and pregnenolone hemisuccinate without any change 
in NMDAR subunit expression [30]. 
EFFECTS OF ETHANOL ON NMDAR SUBUNIT EX-
PRESSION  
 Several  in vivo and in vitro studies showed that chronic 
ethanol treatment leads to an increased density of NMDARs 
leading to facilitation of receptor functions [48, 50, 69, 70, 
71, 122, 189]. For instance, binding of the channel blocking 
agent [
3H]MK-801 to brain membranes from rats exposed to 
severe alcohol intoxication was increased by 49% after the 
last alcohol dose compared with the control group [62]. 
However,nochronic ethanol exposition-related up-regulation 
of NMDAR expression was found in other studies [44, 158]. 
  Consistently with the recently emerged view, increased 
NMDAR function to ethanol treatment is presumably due to 
a differential up-regulation of the various NMDAR subunits. 
Notwithstanding, there is a disagreement in respect of the 
expression of different NMDAR subunits and NR1 splice 
variant forms. Some authors reported no changes in subunit 
expression at all [23], while others found changes in the ex-
pression of multiple types of subunits or solely in the expres-
sion of the NR1 [46] or the NR2A [34] subunit in conse-
quence of long-term ethanol exposure. Numerous in vitro
studies showed increased NR2B subunit mRNA levels, with 
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tured cortical neurons following chronic ethanol administra-
tion [61, 70, 119]. For example, although the NMDAR func-
tion was enhanced in the lateral/basolateral amygdala and the 
increase in the NMDAR current density was associated with 
an increase in ifenprodil inhibition after chronic ethanol in-
gestion, quantitative real-time reverse transcription-poly-
merase chain reaction (qRT-PCR) measurements demon-
strated no changes in NR2 or NR3 subunit transcription [46, 
188]. In another study, there were not significant changes 
observed in any of the NMDA subunit mRNA and protein 
expressions suggesting that the functional NMDA receptor 
adaptations are likely to be mediated by post-translational 
events [90]. 
  On the contrary, there are several reports in which the 
levels of NR2B as well as NR2A and NR1 subunit proteins 
were found increased in the cortex and hippocampus of etha-
nol treated rats or mice [47, 48, 64, 76, 89, 127, 176]. Simi-
larly, exposure to 50 mM ethanol caused an increase in the 
levels of NR1, NR2A and NR2B subunits in cultures of rat 
hippocampal neurons. In addition, the NMDAR antagonist 
compound memantine completely blocked the ethanol-
induced up-regulation of these subunits [110]. Also, after 
chronic ethanol treatment (CET), when rats were exposed to 
continuous ethanol vapors for at least 2 weeks, the mRNA 
levels of NR1 and NR2B NMDAR subunits were signifi-
cantly increased compared to control. Western blot analysis 
revealed a significant increase in NR1 and NR2B NMDAR 
subunit proteins occurred in central nucleus of the amygdala 
from chronically ethanol treated rats that reversed after 2 
weeks of withdrawal [149]. In addition, higher NR2B 
subunit level was found in cultured cerebellar granule cells, 
resulting in a delay in the 'developmental switch' of the 
NR2B subunit for NR2A [164]. 
  In accordance with the above observations, the maximal 
inhibitory effect of ethanol as well as some NR2B subunit 
selective NMDAR antagonists on NMDA evoked cytosolic 
calcium elevations was significantly increased in ethanol 
pre-treated primary cultures of cortical as well as hippocam-
pal neurons obtained from rats. On the other hand, the effi-
ciency of the non-subunit selective NMDAR antagonists, the 
channel blocker MK-801 and the glycine site specific 5,7-
DCK was not changed. Correspondingly, increased expres-
sion of the NR2B subunit protein could be detected by ap-
plyinga flow cytometry-based immunocytochemical method. 
This quantitative analysis showed that whereas the non 
splice variant specific immuno-staining of the NR1 and the 
subunit specific immuno-staining of the NR2A, NR2C, and 
NR2D subunits were not changed, the NR2B specific im-
muno-labeling was increased in a subpopulation of cells in 
ethanol pre-treated compared to control cultures. In further 
studies, when the expression of the different NR1 splice 
variants was investigated, in addition to the NR2B subunits, 
the expression of the C1 (exon 21) and C2’ (exon 22) cas-
sette containing splice variants was found to be increased in 
ethanol pre-treated hippocampal cultures [126]. 
  The molecular mechanisms underlying these changes in 
subunit expression, i.e. the effect of ethanol on the regulation 
of subunit transcription is still an open question. First results 
concerning the regulation of NMDAR subunit composition 
showed that the methylation status of the NR2B gene was 
altered following chronic ethanol treatment in mouse cortical 
neurons [147]. The authors found that demethylation of this 
gene could be responsible for the up-regulation of the NR2B 
subunit expression. Although methylation in CpG islands in 
the regions (5843-6276) and (6477-6763) of the NR2B gene 
was not influenced by acute ethanol treatment, chronic etha-
nol promoted demethylation in this area suggesting that de-
methylation is likely to contribute to the increased expres-
sion of the NR2B gene. In another experiment, it was shown 
that a 467 base-pair DNA fragment of the NR2B promoter 
containing the cAMP responsive element (CRE) sequence 
cloned into a luciferase reporter vector exhibited high activ-
ity in transient co-transfection assay of mouse cortical neu-
rons, and ethanol treatment increased this activity. Introduc-
ing site-directed mutation in the CRE sequence significantly 
reduced the reporter activity relative to the wild-type con-
struct, and it also abolished the stimulatory effect of ethanol. 
These results indicate that CRE binding protein (CREB) is 
probably involved in the mediation of ethanol-induced up-
regulation of the NR2B gene [146]. 
  Another study addressed the role of the neuron-restrictive 
silencer factor (NRSF) - a transcriptional repressor of multi-
ple neuronal genes - in NR2B promoter activity and the mo-
lecular mechanisms of ethanol-induced NR2B up-regulation 
in fetal cortical neurons [143]. Neuron-restrictive silencer 
element (NRSE) motifs located between base pair -1407 and 
-2741 repressed transcription of the NR2B gene. Treatment 
of cultured cortical neurons with 100 mM ethanol for 5 days 
caused a significant decrease in the NRSF mRNA and pro-
tein levels, NRSF/NRSE binding activity, and an increase in 
the promoter activity. Therefore, it was suggested that NRSF 
acting as a negative regulator of NR2B expression may con-
tribute to the ethanol-induced up-regulation of the NR2B 
gene in fetal cortical neurons. One more factor, the tissue-
plasminogen activator (tPA), a protease implicated in neu-
ronal plasticity and seizures, is also thought to interact with 
NR2B-containing NMDA receptors and suggested to play a 
role in up-regulation of the NR2B subunit in response to 
ethanol. tPA is induced in the limbic system by chronic etha-
nol consumption, temporally coinciding with up-regulation 
of NMDA receptors. Furthermore, tPA-deficient mice have 
reduced NR2B, extracellular signal-regulated kinase 1/2 
phosphorylation and seizures after ethanol withdrawal (EW), 
and tPA-mediated facilitation of EW seizures was abolished 
by the NR2B-specific NMDA antagonist ifenprodil. These 
results indicate that tPA may mediate the development of 
physical dependence on ethanol by regulating NR2B-
containing NMDA receptors [137]. 
  Regarding the effect of ethanol on NR1 subunit expres-
sion, Kumari and co-workers observed that chronic ethanol 
exposure of fetal cortical neurons selectively increased the 
expression of NR1 splice variants lacking exon 5 and exon 
22 [89]. Also the half-life of NR1 mRNAs was increased in 
neurons chronically exposed to ethanol. However, when new 
protein synthesis was inhibited, the NR1 mRNA half-life 
returned to control values, strongly suggesting that ethanol 
induced the synthesis of certain protein(s) that may regulate 
the decay of NR1 mRNA. In recent years, it has become 
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aspect of regulation of gene expression. Changes in mRNA 
stability can be accomplished by interaction between cis-
acting sequences in the 3' untranslated region (3'UTR) of 
mRNAs and trans-acting proteins. Such interactions may 
protect RNAs from degradation by ribonucleases, thereby 
increasing the half-life of mRNAs. Another possible mecha-
nism regulating mRNA half-life is RNA interference. RNA 
interference (RNAi) is a process whereby small non-coding 
RNAs (microRNAs) silence specific genes. So far, there is 
no data available regarding the regulation of NMDAR ex-
pression by microRNAs. 
EFFECTS OF ETHANOL ON PROTEIN-PROTEIN 
INTERACTIONS 
Altered Post-Translational Modifications of NMDARs  
  The most frequent post-translational modification of a 
newly synthesized protein is phosphorylation, i.e. the addi-
tion of a phosphate group to serine, threonine, or tyrosine 
residues of a protein substrate. This reaction is achieved via
activation of different protein kinases classified into three 
groups: serine/threonine kinases, tyrosine kinases, and dual-
specificity kinases, which are able to phosphorylate all three 
residues. The opposite reaction, i.e. dephosphorylation, in 
which a phosphate group is removed from a protein, is per-
formed by either serine/threonine or tyrosine phosphatases. 
Whereas receptor kinases and phosphatases are integral parts 
of the plasma membrane, the non-receptor kinases and phos-
phatases reside intracellularly. Kinases and phosphatases are 
specifically activated by signals that are usually transduced 
from outside to inside the cell. For example, activation of 
membrane receptors results in the generation of second mes-
sengers which can in turn initiate signaling cascades includ-
ing the activation of kinases and/or phosphatases. The phos-
phorylation state of a protein therefore reflects the balance 
betweenphosphorylationanddephosphorylationevents [155]. 
  Phosphorylation plays a central role in regulation of 
NMDAR function. It results in the enhancement of channel 
function because application of tyrosine kinase inhibitors 
inhibits whereas that of tyrosine kinases (e.g. Src kinase) 
enhances NMDAR-mediated currents [25, 182, 200, 201]. 
Many NMDAR functions have been linked to tyrosine phos-
phorylation of the NR2 subunits of the NMDAR. NR2A and 
NR2B are phosphorylated on serine and tyrosine residues, 
and the alternatively spliced isoforms of the NR1 subunit is 
phosphorylated on serine residues. The highly homologous 
tyrosine kinases Fyn and Src have been implicated thus far in 
phosphorylating the NR2 subunits on tyrosine residues on 
sites depicted in Fig. (4) [82, 128, 167, 170, 173, 196]. It is 
unclear, however, whether both kinases phosphorylate both 
subunits under physiological conditions, or which sites are 
phosphorylated by which kinase, and whether different sig-
naling pathways activate the two kinases. Both Fyn and Src 
have been implicated in playing an important role in devel-
opment of long term potentiation (LTP). NR2B phosphoryla-
tion is enhanced after the induction of (LTP) in the CA1 re-
gion of the hippocampus [83, 128], whereas inhibitors of the 
Src tyrosine kinases prevent the appearance of LTP [105]. In 
addition, LTP is blunted in mice in which the fyn gene was 
deleted [56]. Tyrosine phosphorylation of NR2 subunits has 
also been found to regulate the trafficking of these subunits 
in striatal neurons [40]. In addition, tyrosine phosphorylation 
of the NR2 subunits was observed in taste aversion learning 
[156], during transient global ischemia [168], and after acute 
injection of hypnotic doses of ethanol [115, 197]. 
Fig. (4). Phosphorylation sites of NMDAR subunits.  
The N-methyl-D-aspartate (NMDA) receptor subunits are phosphorylated on serine and tyrosine residues. Depicted are the amino acid se-
quences of the cytoplasmic tails of rat NR1, NR2A, and NR2B subunits. The N-terminus faces the membrane, and the C terminus is facing 
inward. The kinase is depicted on the top of each rectangle, and the amino acid residue is depicted at the bottom. PKC, protein kinase C; 
PKA, protein kinase A. 
(Adapted from: Ron, D. (2004) Signaling Cascades Regulating NMDA Receptor Sensitivity to Ethanol. Neuroscientist, 10(4), 325-336.) 46    Current Neuropharmacology, 2008, Vol. 6, No. 1 József Nagy 
  At least in part, the inhibitory effect of ethanol on 
NMDAR function could be due to a change in the phos-
phorylation state of NMDARs. The role of phosphorylation 
to modulate the sensitivity of NMDARs for ethanol has be-
gun to be investigated by Miyakawa et al. [115, 192]. They 
showed that mice deficient in the non-receptor Fyn tyrosine 
kinase were more sensitive to the hypnotic effects of alcohol 
and that this effect was correlated with a lack of phosphory-
lation of the NR2B subunit. This suggested that Fyn kinase 
may regulate ethanol sensitivity of NR2B containing NMDA 
receptors in wild-type animals. Anders et al. [7] examined 
this question directly by using a recombinant expression sys-
tem and found no evidence to suggest that Fyn kinase affects 
the ethanol sensitivity of NR1/NR2B receptors. Interestingly, 
in another study, the inhibitory effect of a high concentration 
of ethanol (100 mM) on NR1/NR2A currents was reduced by 
Fyn kinase. In order to investigate the effect of ethanol on 
thephosphorylationstateofNR1 and NR2 subunits, NMDAR 
complexes were immunoprecipitated from rat cortical slices 
pre-exposed to ethanol. Acute ethanol (100 and 200 mM) 
significantly decreased the tyrosine phosphorylation of NR2 
subunits (Tyr-NR2). Treatment with a tyrosine phosphatase 
inhibitor reduced the inhibition of Tyr-NR2 phosphorylation 
caused by ethanol. This suggests an involvement of tyrosine 
phosphatases in ethanol-induced inhibition of Tyr-NR2 
phosphorylation [43]. Correspondingly, Alvestad et al. found 
that tyrosine phosphorylation of both NR2A and NR2B 
subunits was significantly reduced following in situ exposure 
of hippocampal slices to 100 mM ethanol. 
  Serine/threonine kinases like cAMP-dependent protein 
kinase A (PKA), protein kinase C (PKC), calcium-/calmo-
dulin-dependent protein kinase II (CaM kinase II) and cy-
clin-dependent protein kinase 5 (CDK5) also phosphorylate 
the NMDAR subunits at different sites (Fig. 4). PKA phos-
phorylates the NR1 subunit on residue 897 [93, 174], and 
this phosphorylation has recently been found to be essential 
for dopamine D1 receptor mediated phosphorylation of the 
transcription factor CREB [37]. In addition, activation of 
postsynaptic PKA has been reported to enhance channel ac-
tivity [144] and to be important for the expression of LTP in 
the CA1 region of the hippocampus [39]. In a study of Xu 
and Woodward [194], the inhibitory effect of ethanol on ion 
currents through recombinant NMDA receptors was deter-
mined under conditions designed either to enhance or inhibit 
the activity of PKA. This included treatment of cells with 
cAMP analogs, inclusion of phosphatase inhibitors or puri-
fied PKA in the pipette filling solution, co-expression of 
catalytically active PKA, expression of the NR1 PKA-site 
phosphorylation site mimic (S897D) or by co-expression of 
the PKA scaffolding protein yotiao or the dopamine D1 re-
ceptor. The degree of ethanol inhibition was not affected or 
was slightly enhanced under conditions designed to enhance 
PKA activity. Similarly, alteration in ethanol inhibition of 
NR1/NR2AandNR1/NR2Breceptorswas not observed when 
PKA effects were suppressed by co-expression of either a 
PKIinhibitory peptide or the phosphorylation-defi-cient NR1 
mutants (S897A, S896A, S896A/S897A). In addition, etha-
nol inhibition of NMDA-induced currents in cultured cortical 
or hippocampal neurons was not affected by modulators of 
PKA. However, in another study, rat cortical slices pre-
exposed to ethanol (100 and 200 mM) exhibited a significant 
increase in the phosphorylation of NR1 by PKA at serine 
897 (Ser897-NR1), which was blocked by a PKA inhibitor. 
Moreover, 200 mM ethanol produced a significant increase 
in PKA activity [43]. In spite of these contradictory results 
and taking into account that mice with genetic disruptions in 
cAMP/PKA signaling exhibit increased ethanol sensitivity 
and do not develop tolerance to the sedative effect of ethanol
[171, 180], PKA may play a substantial role in increased 
NMDAR activity induced by chronic ethanol treatment. 
  Another kinase that specifically phosphorylates the NR 
subunits is PKC. PKC phosphorylates serine residues 890 
and 896 on the C1 cassette of the NR1 subunit (Fig. 4) [93, 
174]. Phosphorylation of the C1 cassette regulates the export 
of the NR1 subunit from the endoplasmic reticulum and the 
corresponding forward trafficking of this subunit to the syn-
apse [156]. Furthermore, PKC phosphorylation of the NR2A 
subunit on serine 1416 reduces CaM kinase II binding to 
NR2A [53], and phosphorylation of the NR2B subunit on 
residues serine 1303 and 1323 has been implicated in the 
enhancement of channel function [98]. Finally, PKC activa-
tion indirectly induces the tyrosine phosphorylation of 
NR2A and NR2B subunits [106, 59] via the activation of the 
calcium-dependent tyrosine kinase Pyk2/Cak2 [72]. Sys-
temic ethanol administration alters PKC activity in rat brain. 
PKC expression was increased in the cytosol and decreased 
in the membrane fraction of cerebral cortex. In contrast, 
PKC in the membrane fraction as well as in the cytosol was 
decreased. PKC expression was increased in the membrane 
fraction both at 10 and 60 min post-ethanol administration, 
whereas cytosolic levels were unchanged. Phosphorylation 
of NMDA receptor NR1 subunit was increased 60 min fol-
lowing ethanol administration. These findings suggest that 
acute ethanol administration alters PKC synthesis and trans-
location in an isoform and brain region specific manner that 
leads to alterations in serine phosphorylation of the receptor. 
Furthermore, chronic ethanol pre-treatment of rats (6% v/v 
ethanol in liquid diet for 7 days followed by 7.5% v/v etha-
nol in liquid diet for further 7 days) prevented ethanol-
induced alterations in PKC expression in the membrane frac-
tion, where PKC interacts with ethanol-responsive ion chan-
nels [87]. Pre-treatment with the -isozyme-specific peptide 
PKC inhibitor, gammaV5-3, blocked ethanol-induced trans-
location and also blocked withdrawal hyper-responsiveness 
in rat spinal cord slices showing that PKC mediates ethanol 
withdrawal hyper-responsiveness in spinal motor neurons 
[97]. According to Sultana et al., PKC activity was increased 
in both the membrane and the cytosolic fraction of cerebellar 
cells taken from alcohol-treated rats (6 g/kg ethanol per day 
for 60 days), whereas PKC activity in cerebral cortex was 
found to be decreased in the membrane fraction with no ap-
preciable changes in the cytosolic fraction. According to an 
in vitro phosphorylation study, the NR2A subunit was hypo-
phosphorylated in cerebral cortex and cerebellum of ethanol-
treated rats [166]. In addition, ethanol did not affect the 
phosphorylation of the NR1 subunit by PKC at serine 896 in 
rat cortical slices pre-exposed to 100 and 200 mM ethanol 
[43]. 
  CaM kinase II also phosphorylates NR2B by directly 
interacting with the subunit [11], and phosphorylating its 
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activation of this kinase is directly linked to the activation of 
the NMDAR channel and the subsequent entry of calcium 
ions [11, 94]. It is unclear, however, whether CaM kinase II 
and PKC phosphorylate the same site in vivo and whether 
phosphorylation of this site leads to the same or different 
functional consequences.  
  Finally, CDK5 has recently been shown to be activated in 
forebrainischemia, resulting in the phosphorylation of NR2A 
on serine 1232, and consequently leading to CA1 hippocam-
pal neuronal cell death [181]. Effect of ethanol on the activ-
ity of this kinase is not yet published. 
  As mentioned above, the phosphorylation state of a pro-
tein reflects the balance between the activity of kinases and 
phosphatases, and thus phosphatases also play a critical role 
in regulating NMDAR activity. The serine and threonine 
phosphatases, calcineurin (also known as PP2B) and protein 
phosphatase 1 (PP1), are highly important for the regulation 
of the phosphorylation state and thus functions of NMDARs 
[60]. Calcineurin requires binding of calcium/calmodulin for 
its activation and in turn regulates the activity of PP1 via
dopamine and cAMP-regulated phosphoprotein with molecu-
lar weight of 32 kDa (DARPP-32). DARPP-32 is expressed 
predominantly in the medium spiny dopaminergic neurons of 
the neostriatum, and it is an important regulator of numerous 
functions including the regulation of the NMDAR. The ac-
tivity of DARPP-32 depends on its phosphorylation state. 
Activation of the cAMP/PKA pathway leads to DARPP-32 
phosphorylation on serine 34, and upon phosphorylation, 
DARPP-32 potently inhibits the phosphatase PP1 [58]. Acti-
vation of the cAMP/ PKA pathway also leads to the phos-
phorylation of NR1 by PKA, and the phosphorylation con-
tributes to the enhancement of channel activity, whereas PP1 
dephosphorylates the subunit. This NR1 phosphorylation, 
together with the inhibition of PP1 by phospho-DARPP-32, 
keeps the NR1 subunit in a phosphorylated state. Activation 
of the NMDAR and the accompanying increase in calcium 
result in the activation of calcineurin, which dephosphory-
lates both the NR1 subunit and DARPP-32 and leads to a 
reduction in channel activity [58]. Recently it was reported 
that this DARPP-32/PP1 cascade is an important regulatory 
mechanism for neostriatal NMDARs in the presence of etha-
nol [109]. Ethanol, like other drugs of abuse, increases do-
pamine release in the neostriatum [84]. Maldve and col-
leagues found that the activation of the cAMP/PKA pathway 
via the dopamine D1 receptor (D1R) leads to both phos-
phorylation of NR1 and DARPP-32. The combination of 
NMDAR phosphorylation and the inhibition of PP1 results 
in the reduction of the inhibitory action of ethanol on the 
NMDAR. Interestingly, ethanol itself (via a mechanism that 
has not yet been identified) mediates the phosphorylation of 
DARPP-32, contributing to the enhancement of NMDAR 
channel activities. Importantly, this disinhibition of NMDAR 
channel activity, via ethanol and the release of dopamine, is 
likely to be an important factor in NMDAR-dependent LTP, 
a process considered important for long-term neuroadapta-
tions to ethanol [109]. In addition, Edwards and co-workers 
reported that although in vivo administration of a dopamine 
D1R agonist resulted in an increase in the phosphorylation 
state of both NR1 and DARPP-32, treatment with dopamine 
D2 receptor (D2R) agonist (which results in an inhibition of 
the cAMP/PKA pathway) significantly reduced the activities 
of the D1R agonist when both drugs were co-administered. 
Ethanol, however, reversed the inhibitory effect of D2R acti-
vation, suggesting that ethanol in the neostriatum is synergiz-
ing with dopamine D1R to increase NR1 and DARPP-32 
phosphorylation, and by doing so, ethanol is masking the 
effects mediated by D2Rs [41]. Last, the contribution of 
DARPP-32 to ethanol-mediated behaviors was tested using 
the DARPP-32 deletion mutant mice (DARPP-32
-/-) [148]. 
DARPP-32
-/- mice consume less ethanol compared to the 
wild-type control mice and are less responsive to the reward-
ing actions of ethanol as measured by the conditioned place 
preference paradigm, further implicating DARPP-32 as an 
important specific regulator of ethanol’s behavioral effects. 
Altered Regulation of NMDAR Functions by Other Re-
ceptors 
  In chronically cannulated rats it was found that injection 
of the group I mGluR agonist 3,5-dihydroxyphenylglycine 
(DHPG) into the caudate putamen significantly increased 
phosphorylation of the two serine residues (serine 896 and 
serine 897) on the intracellular C-terminus of the NR1 
subunit. The increase in NR1 phosphorylation was dose-
dependent and DHPG had no effect on basal levels of NR1 
proteins. Intrastriatal infusion of the group I mGluR anta-
gonist N-phenyl-7-(hydroxyimino)cyclopropa[b]chromen-1a-
carboxamide (PHCCC) significantly attenuated the DHPG-
stimulated NR1 phosphorylation. Pretreatment with the 
mGluR5 antagonist 2-methyl-6-(phenylethynyl) pyridine 
hydrochloride (MPEP) also produced the same effect. These 
data suggest that group I mGluRs, likely mGluR5 receptors, 
possess the ability to up-regulate protein phosphorylation of 
NMDA receptor NR1 subunits in striatal neurons in vivo
[26]. 
  Recently, evidence has emerged that acamprosate, a 
novel abstinence-promoting agent may interact with excita-
tory glutamatergic neurotransmission in general and as an 
antagonist of the metabotropic glutamate receptor subtype 5 
(mGluR5) in particular. These findings provide, for the first 
time, a satisfactory, unifying hypothesis that can bring to-
gether and explain the diverse neurochemical effects of 
acamprosate [36]. Acamprosate has been shown to block the 
changes in phosphorylation of the NMDAR following 
mGluR5 receptor activation. The basal phosphorylation state 
of the NMDAR is likely to be different in alcohol-naive neu-
rons than in neurons that have been chronically exposed to 
ethanol because of various adaptive changes in the NMDAR. 
The indirect action of acamprosate on NMDAR function 
may differ according to the phosphorylation state of the 
NMDAR and this may therefore provide an explanation for 
the selective effect of acamprosate on behaviors related to 
excessive chronic alcohol consumption compared with those 
related to acute or occasional alcohol exposure. The second 
functionally important effect of acamprosate relates to an 
action at mGluR5 receptors that occurs at the presynaptic 
level. Glutamate released from glutamatergic nerve terminals 
activates mGluR5 receptors on the synaptic bouton. The sub-
sequent activation of phospholipase C and release of intra-
cellular second messengers mobilize intracellular calcium 
and thus potentiates transmitter release [165, 172]. This 
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tamate release. Acamprosate may block this positive feed-
back loop and thereby attenuate large surges in glutamate 
release that occur when the CNS is hyper-excitable, for ex-
ample following alcohol withdrawal. 
  It was also demonstrated that cerebellar adenosine modu-
lates ethanol-induced motor incoordination via A(1) subtype 
of adenosine receptors. The adenosine A(1)-selective agonist 
N(6)-cyclohexyladenosine and antagonist 8-cyclopentyl-1,3-
dipropylxanthine functionally opposed the attenuation by 
glutamate and NMDA and the accentuation by L-glutamic 
acid diethyl-ester, AP-5, and (+)-MK-801, respectively, of 
ethanol-induced motor incoordination. These results suggest 
a functional antagonism between glutamate NMDA and 
adenosine A(1) receptors exhibiting a co-modulation of 
ethanol-induced motor incoordination within the cerebellum 
[33]. 
  Current responses to NMDA in layer V pyramidal neu-
rons of the rat prefrontal cortex were found to be potentiated 
by the P2 purine receptor agonists, adenosine 5'-triphosphate 
(ATP) and uridine 5'-triphosphate (UTP). It was suggested 
that exogenous and probably also endogenous ATP releases 
vesicular glutamate from astrocytes via P2Y4 receptor acti-
vation. This glutamate then stimulates group I metabotropic 
glutamate receptors (mGluRs) of layer V pyramidal neurons 
and via the Gq - phospholipase C - inositol 1,4,5-trisphos-
phate - Ca
2+ - CAMKII transduction pathway facilitates 
NMDA receptor currents [189]. 
Altered Compartmentalization of NMDAR Subunits 
In response to prolonged ethanol exposure, neuroadaptive 
changes in NMDARs may occur also through processes that 
regulate the synaptic targeting and localization of these re-
ceptors [155]. Carpenter-Hyland et al. [22], who used confo-
cal imaging and electrophysiology procedures to assess the 
effects of prolonged ethanol exposure on NMDA receptor 
trafficking in cultures of hippocampal neurons found an in-
crease in the dendritic clustering of NMDARs in neurons 
exposed to 50 - 100 mM ethanol for 4 days. This increase 
was prevented by addition of the PKA inhibitor KT-5720 or 
by co-exposure to a low concentration of NMDA and was 
reversed when ethanol was removed from the cultures. Quite 
the contrary, i.e. no changes were observed in the synaptic 
content or density of AMPA receptors after ethanol expo-
sure. Electrophysiological measurements on ethanol-treated 
neurons revealed a similar enhancement in synaptic NMDA 
currents with no change in AMPA-mediated events. After 
blocking synaptic NMDA receptors by MK801 trapping, 
whole-cell responses to NMDA were not different between 
control and ethanol-treated neurons.
  NMDARs are important components of the postsynaptic 
density (PSD) structure within postsynaptic membranes of 
glutamatergic neurons built up of adhesion molecules and 
numbers of scaffolding/anchoring proteins [79, 80, 162]. 
Scaffolding proteins are essential for forming connections 
between trans-membrane receptors with cytoskeleton, for the 
assembly of kinases and phosphatases in close proximity 
with receptor molecules (e.g. with NMDARs), and thus for 
the regulation of activity of signaling proteins within the 
PSD [131, 73, 179]. More than 80 proteins have been identi-
fied within the PSD complex [73, 179]. NMDARs are linked 
to the cytoskeleton via the cytoskeleton-associated proteins 
-actinin-2 and spectrin, which interact with both NR2B and 
NR1 subunits [193, 183]. In the presence of calcium, calmo-
dulin competes with and prevents -actinin-2 from binding 
to NR1, presumably leading to NMDAR rundown and to 
redistribution of the channel (Fig. 1) [193]. 
  Another major scaffolding protein in the PSD is PSD-95 
[55]. PSD95, as well as its homologous proteins PSD93, 
SAP97, and SAP102, directly interacts with NR2A and 
NR2B via its first two PDZ domains. Association of PSD95 
with NR2A and/or NR2B subunits is thought to be important 
for the compartmentalization of the NMDAR complex 
within the PSD, for channel clustering, and for the recruit-
ment of signaling proteins in close proximity to the NMDAR 
complexes [10, 85, 129]. However, in a recent study Lim et
al. [100] using peptides that disrupt the PSD95/NMDAR 
interaction reported only moderate inhibition of clustering of 
the receptor. They have not found any changes in NMDAR-
mediated currents either, suggesting that the interaction is 
not crucial for the activity of the channel. 
  Another anchoring protein important for the regulation of 
the phosphorylation state and function of the NMDARs is 
yotiao. Yotiao is a 230-kDa protein recognized by a two-
hybrid screen for NR1-interacting proteins [101]. Yotiao was 
also identified as a PKA-anchoring protein that associates 
with PP1 [184]. Under resting conditions, interacting with 
NR1 and active PP1, it ensures the phosphatase to keep NR1 
in a dephosphorylated state. However, upon activation of the 
cAMP/PKA signaling pathway, the catalytic subunit of PKA 
phosphorylates NR1 to overcome the activity of the phos-
phatase, leading to PKA-mediated enhancement of channel 
activity. 
  A further scaffolding protein that associates with 
NMDARs is RACK1. RACK1 is a 36-kDa ubiquitously ex-
pressed protein that is highly expressed in the brain. RACK1 
was originally cloned and identified as a protein kinase C 
(PKC) anchoring protein [151]. Lately, several further pro-
teins have been identified which interact with RACK1 [111, 
155], including signaling proteins such as the phosphodi-
esterase PDE4D5 [199], the tyrosine phosphatase PTPF
[121], kinases such as Fyn [195], and intracellular tails of 
different receptors such as -integrin [99], GABAA [20], the 
insulin-like growth factor receptor [81], and the NMDAR 
[195]. The interaction of RACK1 with proteins allows the 
compartmentalization of signaling proteins and the regula-
tion of diverse cellular activities [111]. A unique feature of 
RACK1 is its ability to translocate to different intracellular 
compartments upon activation of specific signal transduction 
cascades. For example, activation of the PKC signaling path-
way induces RACK1 to translocate together with IIPKC to 
its substrate site [151, 152, 153], whereas activation of the 
PKA pathway induces RACK1 translocation to the nucleus 
[154, 63, 196]. Nuclear RACK1 in turn alters the expression 
of several genes [63, 196]. More recently, RACK1 has been 
found to be an important regulator of ribosome assembly and 
activation via its interaction with IIPKC [24]. 
  RACK1 is also an important regulator of the phosphory-
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association between RACK1 and the NMDAR is subunit 
specific. Only NR2B, but not NR2A or NR1, binds RACK1 
[195]. NR2B is a substrate of Fyn kinase, and RACK1 si-
multaneously binds both proteins. RACK1 prevents the abil-
ity of the kinase to phosphorylate the channel, leading to the 
inhibition of NMDAR-mediated excitatory postsynaptic po-
tentials [195]. The release of RACK1 from the NMDAR 
complex via activation of the cAMP/PKA pathway allows 
Fyn to phosphorylate NR2B specifically, and this phos-
phorylation in turn enhances the function of the channel 
[196].  
  Interestingly, formation of this tri-molecular complex is 
not ubiquitously observed in the brain. In the hippocampus, 
RACK1 is localized at the plasma membrane, where it scaf-
folds Fyn to the NMDAR. However, in the cortex, RACK1 
is found mainly in the cell soma, and therefore it is not capa-
ble of compartmentalizing Fyn with the NMDAR. This spe-
cific compartmentalization of Fyn to the NMDAR complex 
via RACK1 may play a role in the actions of ethanol on the 
channel.Inthe hippocampus, upon ethanol treatment RACK1 
is released from the NMDAR complex in a mechanism that 
depends on the activation of the cAMP/PKA signaling cas-
cade. The dissociation of the tri-molecular complex enables 
Fyn to phosphorylate NR2B. These changes lead to phos-
phorylation-dependent enhancement of NMDAR channel 
activity during exposure to ethanol, leading to the develop-
ment of acute desensitization and to a rebound potentiation 
of the channel activity when ethanol is washed out. How-
ever, in the cortex, because Fyn is not compartmentalized 
near NR2B, ethanol exposure does not result in changes in 
the phosphorylation state of the subunit [77, 197] and only 
the inhibition of channel activity but not the rebound poten-
tiation following ethanol washout or the development of 
acute desensitization could be observed [197]. Together, 
these results suggest that in brain regions where the phos-
phorylation state of NR2B is regulated by the compartmen-
talization of Fyn via RACK1, ethanol’s actions on the 
NMDAR channel are the outcome of two opposing activi-
ties: 1) an increase in activity due to the release of RACK1 
and the phosphorylation of NR2B by Fyn and 2) a decrease 
in activity due to the direct inhibitory activity of ethanol on 
the NMDAR as previously documented [102]. In addition, 
these results suggest a mechanism by which ethanol alters 
the phosphorylation state of a specific NMDAR subunit. 
This specificity of ethanol activity on the NR2B subunit in 
some brain regions but not in others is likely to contribute to 
the behavioral effects of ethanol, such as acute sensitivity to 
the hypnotic effects of ethanol, that are likely to be mediated 
via hippocampal Fyn and NR2B [115, 198]. 
SUMMARY  
There is convincing preclinical evidence suggesting that 
adaptive processes taking place in the central nervous system 
in response to chronic ethanol administration contribute to 
the development of tolerance, dependence and withdrawal 
symptoms. Since NMDA receptors are among the highest-
affinity targets for ethanol’s inhibition in the brain [57, 86], 
one of the most important adaptive changes may be the al-
tered expression of these receptors. Up-regulation of 
NMDARs will result in the reduction of ethanol’s effect (tol-
erance), and accompanying neurochemical changes will lead 
to complex behavioral symptoms called ethanol dependence. 
Furthermore, the altered balance between excitatory and in-
hibitory processes will manifest in withdrawal symptoms 
when alcohol intake is ceased. The cellular events underlying 
the enhanced functioning of NMDARs in consequence of 
prolonged ethanol exposure include changes in the regulation 
of subunit expression, localization, post-translational modifi-
cations and interactions with other receptors or regulatory 
proteins. Better understanding of these processes can expand 
our knowledge on ethanol’s action that may establish new 
strategies for the treatment of alcohol-related diseases.
  Our aim with this review was to summarize and give a 
complex view about all these events supposedly playing a 
regulatory role in the up-regulation of NMDAR functions in 
consequence of chronic ethanol exposure. In response to 
chronic blockade of NMDA receptors due to sustained etha-
nol administration, agonist and co-agonist induced NMDA 
receptor activation was shown to be enhanced. The aug-
mented agonist activity is mostly accompanied with an in-
crease in mRNA as well as protein levels of the NR1 and 
certain NR2, especially the NR2A and NR2B subunits [176, 
88, 126]. The molecular mechanisms underlying these 
changes may consist of certain events in regulation of gene 
expression such as demethylation of the NR2B gene, en-
hanced NR2B promoter activity or down-regulation of a re-
pressor (NRSF) of NR2B expression upon ethanol exposure. 
Regulatory steps occurring at the level of translation e.g. 
alterations in the half-life of NR1 mRNAs supposedly due to 
RNAi (microRNA) mechanisms may also contribute to these 
changes in subunit expression. Other regulatory events influ-
encing the activity of NMDARs are the post-translational 
modifications, especially the phosphorylation state of the 
receptor. Activity of several kinases (Src, Fyn, PKA, PKC, 
CaM kinase II, CDK5) and phosphatases (PP1, PP2B) on 
NMDAR subunit phosphorylation was shown to be affected 
by ethanol leading to altered ethanol sensitivity and/or func-
tional activity of NMDARs. As main structural components 
of the postsynaptic density, several scaffolding proteins like 
PSD-95, RACK1 and Yotiao also modulates the phosphory-
lation state of the NMDARs. These proteins and other cy-
tosceletal elements regulating subunit assembly and distribu-
tion of NMDARs within different cell compartments, like -
actinin-2 and spectrin, as well as their synaptic/non-synaptic 
localization may influence glutamate sensitivity, therefore 
activity of certain neurons. There are some observations de-
scribing altered functions of these components regulating 
NMDAR functions upon ethanol exposure. Finally, ethanol 
also influences the co-operation of NMDARs with other neu-
rotransmitter receptors such as mGluRs, dopamine, purine 
and adenosine receptors. Therefore, ethanol acting on the 
inter-receptor communication as well as on the above men-
tioned regulatory processes may contribute to its behavioral 
effects and to the development of alcohol tolerance, depend-
ence and to the manifestation of withdrawal symptoms. 
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